China Biotech Services Holdings Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was HKD 211.99 million compared to HKD 1,851.53 million a year ago. Net loss was HKD 95.45 million compared to net income of HKD 258.09 million a year ago.

Basic loss per share from continuing operations was HKD 0.099 compared to basic earnings per share from continuing operations of HKD 0.268 a year ago.